Filing Details

Accession Number:
0001387131-15-000444
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-02-10 15:55:27
Reporting Period:
2015-02-06
Filing Date:
2015-02-10
Accepted Time:
2015-02-10 15:55:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1173281 Ohr Pharmaceutical Inc OHRP Pharmaceutical Preparations (2834) 465622433
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1579887 Samuel Backenroth C/O Ohr Pharmaceutical, Inc.
800 Third Ave., 11Th Floor
New York NY 10022
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Per Share Acquisiton 2015-02-06 1,500 $6.75 6,199 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Option $1.50 2010-04-12 2015-04-12 66,667 66,667 Direct
Common Stock Option $1.71 2014-03-09 2017-03-09 133,333 133,333 Direct
Common Stock Option $10.11 2014-02-03 2017-02-03 250,000 250,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2015-04-12 66,667 66,667 Direct
2017-03-09 133,333 133,333 Direct
2017-02-03 250,000 250,000 Direct
Footnotes
  1. All exercisable.
  2. 33,333 options are currently unexercisable until March 9, 2015.
  3. 125,000 options are currently unexercisable; half will become exercisable February 3, 2015 and half will become exercisable February 3, 2016.